176 related articles for article (PubMed ID: 23510771)
1. The Global Alliance for Vaccines and Immunization (GAVI).
Schwalbe N
Vaccine; 2012 Nov; 30 Suppl 4():x. PubMed ID: 23510771
[No Abstract] [Full Text] [Related]
2. Executive summary.
Vaccine; 2012 Nov; 30 Suppl 4():xi. PubMed ID: 23510772
[No Abstract] [Full Text] [Related]
3. The path to eliminate cervical cancer in the world and the challenges of professional education.
Bosch FX
Vaccine; 2012 Nov; 30 Suppl 4():viii-ix. PubMed ID: 23510770
[No Abstract] [Full Text] [Related]
4. The announcement by the GAVI Alliance Board to support human papillomavirus (HPV) vaccines in the world's poorest countries.
Vaccine; 2012 Nov; 30 Suppl 4():xii. PubMed ID: 23510773
[No Abstract] [Full Text] [Related]
5. Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report.
de Sanjosé S; Serrano B; Castellsagué X; Brotons M; Muñoz J; Bruni L; Bosch FX
Vaccine; 2012 Nov; 30 Suppl 4():D1-83, vi. PubMed ID: 23510764
[No Abstract] [Full Text] [Related]
6. Human papillomavirus, vaccines and women's health: questions and cautions.
Lippman A; Melnychuk R; Shimmin C; Boscoe M
CMAJ; 2007 Aug; 177(5):484-7. PubMed ID: 17671239
[No Abstract] [Full Text] [Related]
7. Global elimination of cervical cancer is achievable-with commitment.
The Lancet Oncology
Lancet Oncol; 2019 Nov; 20(11):1467. PubMed ID: 31674306
[No Abstract] [Full Text] [Related]
8. Controlling cervical cancer.
Bonati M; Garattini S
Pharmacoeconomics; 2009; 27(2):91-3. PubMed ID: 19254043
[No Abstract] [Full Text] [Related]
9. Human papillomavirus vaccine: waiting for a miracle.
MacDonald N; Hébert PC
CMAJ; 2007 Aug; 177(5):433, 435. PubMed ID: 17724313
[No Abstract] [Full Text] [Related]
10. Rebuttal: Do you approve of spending $300 million on HPV vaccination? No.
Lippman A; Boscoe M; Scurfield C
Can Fam Physician; 2008 Mar; 54(3):343, 345. PubMed ID: 18337522
[No Abstract] [Full Text] [Related]
11. Implementation of human papillomavirus immunization in the developing world.
Kane MA; Serrano B; de Sanjosé S; Wittet S
Vaccine; 2012 Nov; 30 Suppl 5():F192-200. PubMed ID: 23199963
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus.
Brody H
Nature; 2012 Aug; 488(7413):S1. PubMed ID: 22932432
[No Abstract] [Full Text] [Related]
13. Cervical cancer: who's at risk?
McCormish E
Nurs Womens Health; 2011 Dec; 15(6):476-83. PubMed ID: 22900688
[TBL] [Abstract][Full Text] [Related]
14. Latin America. Price is the main barrier to wider use of papillomavirus vaccine.
Kaiser J
Science; 2008 May; 320(5878):860. PubMed ID: 18487164
[No Abstract] [Full Text] [Related]
15. Clinical update: human papillomavirus vaccine.
Deneris A; Bond S
J Midwifery Womens Health; 2006; 51(6):515-8. PubMed ID: 17081944
[No Abstract] [Full Text] [Related]
16. Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda.
Kamya C; Shearer J; Asiimwe G; Carnahan E; Salisbury N; Waiswa P; Brinkerhoff J; Hozumi D
Int J Health Policy Manag; 2017 Jun; 6(6):327-338. PubMed ID: 28812825
[TBL] [Abstract][Full Text] [Related]
17. HPV vaccination: Clinical potential, implementation challenges, and future directions.
Perkins RB
Hum Vaccin Immunother; 2016 Jun; 12(6):1327-31. PubMed ID: 27294609
[No Abstract] [Full Text] [Related]
18. WHO consultation on human papillomavirus vaccines.
WHO
Wkly Epidemiol Rec; 2005 Sep; 80(35):299-302. PubMed ID: 16180643
[No Abstract] [Full Text] [Related]
19. Prophylactic and therapeutic human papillomavirus vaccine: a breakthrough for women health.
Yousuf S; Syed S
J Pak Med Assoc; 2009 May; 59(5):310-4. PubMed ID: 19438137
[TBL] [Abstract][Full Text] [Related]
20. Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Sankaranarayanan R
Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S205-10. PubMed ID: 17161159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
